
Current Price | $0.79 | Mkt Cap | $76.5M |
---|---|---|---|
Open | $0.83 | P/E Ratio | -1.43 |
Prev. Close | $0.79 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.79 - $0.83 | Volume | 205,807 |
52-Wk Range | $0.47 - $1.77 | Avg. Daily Vol. | 372,371 |
A drug discovery and development company that is seeking to leverage its innovative biological signaling pathway drug technologies to create new medicines primarily in the field of cancer.
Current Price | $0.79 | Mkt Cap | $76.5M |
---|---|---|---|
Open | $0.83 | P/E Ratio | -1.43 |
Prev. Close | $0.79 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.79 - $0.83 | Volume | 205,807 |
52-Wk Range | $0.47 - $1.77 | Avg. Daily Vol. | 372,371 |
The best Bull and Bear pitches based on recency and number of recommendations.
They're having good trial runs on their cancer drugs.
Read the most recent pitches from players about CRIS.
Recs
This company has been around for 20 some odd years, and is NOT friendly to shareholders. Multiple reverse splits. Took forever before they began generating revenue, but even now, they struggle to generate a positive gross margin. Massive losses each quarter and have built up a $1 BILLION accumulated deficit. I have gotten lucky up-thumbing this in the past but it really only deserves a down thumb. Don't waste your hard earned money on this stub. I wouldn't consider shorting this in real life, mostly because bio-techs are so volatile and unpredictable.
Recs
Looking for bump from earnings.
Recs
Short. Biotech. Revenues have dried up. Issuing lots of stock and raising debt. Big losses.
Find the members with the highest scoring picks in CRIS.
Broken196 (< 20) Score: +421.69
The Score Leader is the player with the highest score across all their picks in CRIS.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
Broken196 | < 20 | 9/4/2009 |
![]() |
1Y | $11.85 | -93.26% | +328.44% | +421.69 | 0 Comment | |
Marshal82 | 62.35 | 9/16/2009 |
![]() |
3Y | $11.65 | -93.14% | +303.38% | +396.52 | 0 Comment | |
longtermgrowth09 | 51.50 | 12/17/2009 |
![]() |
5Y | $14.45 | -94.47% | +288.41% | +382.88 | 0 Comment | |
stockjock11 | 45.88 | 6/17/2010 |
![]() |
5Y | $8.95 | -91.07% | +283.01% | +374.08 | 0 Comment | |
shorttest4 | 30.83 | 3/8/2010 |
![]() |
5Y | $15.90 | -94.97% | +276.37% | +371.35 | 0 Comment | |
louisfool | 82.36 | 10/28/2011 |
![]() |
5Y | $18.60 | -95.70% | +234.67% | +330.37 | 2 Comments | |
boardwalken65 | 30.54 | 7/7/2011 |
![]() |
3M | $18.25 | -95.62% | +218.17% | +313.80 | 0 Comment | |
EclecticRecluse | < 20 | 5/4/2011 |
![]() |
3W | $18.60 | -95.70% | +216.98% | +312.68 | 1 Comment | |
rknapton | 33.36 | 8/7/2013 |
![]() |
5Y | $20.50 | -96.10% | +154.18% | +250.28 | 1 Comment | |
Moondoggie | 96.41 | 10/1/2014 |
![]() |
5Y | $7.05 | -88.66% | +118.63% | +207.29 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.